Detection of cell-free RNA in children with neuroblastoma and comparison with that of whole blood cell RNA

Pediatric Blood and Cancer

Volumn 54, Issue 7, 2010, Pages 897-903

  Corrias, Maria Valeria ^a   Pistorio, Angela ^a   Cangemi, Giuliana ^a   Tripodi, Gino ^a   Carlini, Barbara ^a   Scaruffi, Paola ^b   Fardin, Paolo ^a   Garaventa, Alberto ^a   Pistoia, Vito ^a   Haupt, Riccardo ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Cancer; Cell free RNA; Detection; Neuroblastoma; Quantitative real time PCR; Tyrosine hydroxylase

Indexed keywords

RNA; TYROSINE 3 MONOOXYGENASE;

ADOLESCENT; ARTICLE; BLOOD CELL; CELL FREE SYSTEM; CHILD; CONTROLLED STUDY; CONVALESCENCE; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INFANT; MAJOR CLINICAL STUDY; MALE; MONITORING; NEUROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SCHOOL CHILD; STANDARD; TUMOR CELL; WHOLE CELL;

ADOLESCENT; ADULT; BLOOD CELLS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; ELECTROPHORESIS, CAPILLARY; FEMALE; HEMATOLOGIC TESTS; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEUROBLASTOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TUMOR MARKERS, BIOLOGICAL;

EID: 77951719032     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22498     Document Type: Article

References (40)

1. Lo YM, Chiu RW. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis. Clin Chem 2008;54:461-466.
2. Goebel G, Zitt M, Zitt M, et al. Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias. Dis Markers 2005;21:105-120. (Pubitemid 41566728)
3. Chen XQ, Bonnefoi H, Pelte MF, et al. Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res 2000;6:3823-3826.
4. Silva JM, Dominguez G, Silva J, et al. Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin Cancer Res 2001;7:2821-2825. (Pubitemid 32911391)
5. Fleischhacker M, Beinert T, Ermitsch M, et al. Detection of amplifiable messenger RNA in the serum of patients with lung cancer. Ann NYAcad Sci 2001;945:179-188. (Pubitemid 33022451)
6. Kopreski MS, Benko FA, Gocke CD. Circulating RNA as a tumor marker: Detection of 5T4 mRNA in breast and lung cancer patient serum. Ann NYAcad Sci 2001;945:172-178.
7. Silva JM, Rodriguez R, Garcia JM, et al. Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. Gut 2002;50:530-534. (Pubitemid 34638874)
8. El-Hefnawy T, Raja S, Kelly L, et al. Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin Chem 2004;50:564-573. (Pubitemid 38297307)
9. Novakovic S, Hocevar M, Zgajnar J, et al. Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer. Oncol Rep 2004;11:245-252.
10. Miura N, MaedaY, Kanbe T, et al. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma. Clin Cancer Res 2005;11:3205-3209. (Pubitemid 40627866)
11. Schmidt B, Engel E, Carstensen T, et al. Quantification of free RNA in serum and bronchial lavage: Anewdiagnostic tool in lung cancer detection? Lung Cancer 2005;48:145-147.
12. Garcia V, Garcia JM, Pena C, et al. Thymidylate synthase messenger RNA expression in plasma from patients with colon cancer: Prognostic potential. Clin Cancer Res 2006;12:2095-2100.
13. Garcia JM, Pena C, Garcia V, et al. Prognostic value of LISCH7 mRNA in plasma and tumor of colon cancer patients. Clin Cancer Res 2007;13:6351-6358. (Pubitemid 350075024)
14. Silva J, Garcia V, Garcia JM, et al. Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients. Breast Cancer Res 2007;9:R55. (Pubitemid 350187468)
15. Garcia V, Garcia JM, Pena C, et al. Free circulating mRNA in plasma from breast cancer patients and clinical outcome. Cancer Lett 2008;263:312-320.
16. Garcia V, Garcia JM, Silva J, et al. Levels of VEGF-A mRNA in plasma from patients with colorectal carcinoma as possible surrogate marker of angiogenesis. J Cancer Res Clin Oncol 2008; 134:1165-1171.
17. Feng G, Li G, Gentil-Perret A, et al. Elevated serum-circulating RNA in patients with conventional renal cell cancer. Anticancer Res 2008;28:321-326. (Pubitemid 351362920)
18. Maris JM, Hogarty MD, Bagatell R, et al. Neuroblastoma. Lancet 2007;369:2106-2120.
19. Combaret V, Audoynaud C, Iacono I, et al. Circulating MYCN DNAas a tumor-specific marker in neuroblastoma patients. Cancer Res 2002;62:3646-3648. (Pubitemid 34728840)
20. Gotoh T, Hosoi H, Iehara T, et al. Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative polymerase chain reaction. J Clin Oncol 2005;23:5205-5210. (Pubitemid 46224030)
21. Tchirkov A, Paillard C, Halle P, et al. Significance of molecular quantification of minimal residual disease in metastatic neuroblastoma. J Hematother Stem Cell Res 2003;12:435-442. (Pubitemid 36993431)
22. Burchill SA, Lewis IJ, Abrams KR, et al. Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year. J Clin Oncol 2001;19:1795-1801.
23. Trager C, Kogner P, Lindskog M, et al. Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastoma cells in blood and bone marrow. Clin Chem 2003;49:104-112. (Pubitemid 36078559)
24. Ifversen MR, Kagedal B, Christensen LD, et al. Comparison of immunocytochemistry, real-time quantitative RT-PCR and flow cytometry for detection of minimal residual disease in neuroblastoma. Int J Oncol 2005;27:121-129.
25. Corrias MV, Haupt R, Carlini B, et al. Peripheral blood stem cell tumor cell contamination and survival of neuroblastoma patients. Clin Cancer Res 2006;12:5680-5685. (Pubitemid 44629595)
26. Trager C, Vernby A, Kullman A, et al. mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis. Int J Cancer 2008;123:2849-2855.
27. Viprey V, Corrias M, Kagedal B, et al. Standardisation of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: Quality assurance on behalf of SIOPEN-R-NET. Eur J Cancer 2007;43:341-350. (Pubitemid 46123979)
28. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11:1466-1477. (Pubitemid 23228250)
29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408. (Pubitemid 34164012)
30. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310. (Pubitemid 16134762)
31. Wong BC, Lo YM. Cell-free DNA and RNA in plasma as new tools for molecular diagnostics. Expert Rev Mol Diagn 2003;3:785-797.
32. Ding C, Lo YM. MALDI-TOF mass spectrometry for quantitative, specific, and sensitive analysis of DNA and RNA. Ann NY Acad Sci 2006;1075:282-287. (Pubitemid 44532795)
33. Cerkovnik P, Perhavec A, Zgajnar J, et al. Optimization of an RNA isolation procedure from plasma samples. Int J Mol Med 2007;20:293-300.
34. Lee TH, Montalvo L, Chrebtow V, et al. Quantitation of genomic DNA in plasma and serum samples: Higher concentrations of genomic DNA found in serum than in plasma. Transfusion 2001;41:276-282. (Pubitemid 32220522)
35. Thijssen MA, Swinkels DW, Ruers TJ, et al. Difference between free circulating plasma and serum DNA in patients with colorectal liver metastases. Anticancer Res 2002;22:421-425.
36. Jung M, Klotzek S, Lewandowski M, et al. Changes in concentration of DNA in serum and plasma during storage of blood samples. Clin Chem 2003;49:1028-1029. (Pubitemid 36623507)
37. Swinkels DW, Wiegerinck E, Steegers EA, et al. Effects of blood-processing protocols on cell-free DNA quantification in plasma. Clin Chem 2003;49:525-526. (Pubitemid 36250226)
38. Laktionov PP, Tamkovich SN, Rykova EY, et al. Cell-surface-bound nucleic acids: Free and cell-surface-bound nucleic acids in blood of healthy donors and breast cancer patients. Ann NY Acad Sci 2004;1022:221-227.
39. Biggiogera M, Bottone MG, Pellicciari C. Nuclear RNA is extruded from apoptotic cells. J Histochem Cytochem 1998;46:999-1005. (Pubitemid 28402480)
40. Halicka HD, Bedner E, Darzynkiewicz Z. Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis. Exp Cell Res 2000;260:248-256.